Lynette Lee

APAC IPB Operations - Business Manager at Deutsche Bank

Singapore

About

Experience

  • Deutsche Bank (Singapore)
    • APAC IPB Operations - Business Manager
      Dec 2022 - Present · 3 yrs 8 mos

      International Private Bank (IPB)

    • APAC Technology - Business Manager
      Mar 2020 - Nov 2022 · 2 yrs 9 mos

      Country Technology Management

    • Business Management Analyst
      Oct 2018 - Feb 2020 · 1 yr 5 mos

      Country Technology Management

  • Business Analyst at Royal Bank of Scotland
    Mar 2013 - Apr 2016 · 3 yrs 2 mos

  • IT Consultant at FDM Group
    Sep 2011 - Nov 2014 · 3 yrs 3 mos

    Joined the academy as a trainee consultant to further enhance my skills for a career in the banking industry. IT Technical Aspects: - UNIX - Oracle SQL Project Management Methodologies: - Professional Skills - PRINCE2 Testing Qualifications: - ISTQB-ISEB Certified Tester Foundation Level - Manual Testing - Agile Development - QuickTest Professional

  • IT Business Analyst at UBS Investment Bank
    May 2012 - Nov 2012 · 7 mos

    - 1 out of 4 globally placed analysts working in the REX Business Office - Solutions Strategy Team, Global Reconciliations Unit (GRU) IT - Serviced clients from IB, WM&SB and AM; focusing on the APAC region - Review & approve REX New build and enhancements - Provide training sessions for users - Assist users in writing specifications for new builds and enhancements - Assist in providing solutions for the Business users issues and concerns - Provision of regular reporting to Reconciliation Owners - Escalation of timeframe issues to Reconciliation and control team. - Provide L3 support as and when necessary

  • IT Business Analyst at GlaxoSmithKline
    Jun 2009 - Jun 2010 · 1 yr 1 mo

    Undertook small projects and contributed to large-scaleprojects between GSK scientists and the IT department. My work involved interaction with end users (scientists) to understand their IT needs and to offer technology solutions which will aid in accelerating their work performance as well as improve their efficiency in researching new drugs.